Viral and cellular double-stranded RNA (dsRNA) is recognized by cytosolic innate immune sensors, including RIG-I-like receptors. Some cytoplasmic dsRNA is commonly present in cells, and one source is mitochondrial dsRNA, which results from bidirectional transcription of mitochondrial DNA (mtDNA). Here we demonstrate that Trp53 mutant mouse embryonic fibroblasts contain immune-stimulating endogenous dsRNA of mitochondrial origin. We show that the immune response induced by this dsRNA is mediated via RIG-I-like receptors and leads to the expression of type I interferon and proinflammatory cytokine genes. The mitochondrial dsRNA is cleaved by RNase L, which cleaves all cellular RNA including mitochondrial mRNAs, increasing activation of RIG-I-like receptors. When mitochondrial transcription is interrupted there is a subsequent decrease in this immune-stimulatory dsRNA. Our results reveal that the role of p53 in innate immunity is even more versatile and complex than previously anticipated. Our study, therefore, sheds new light on the role of endogenous RNA in diseases featuring aberrant immune responses.

CEITEC Masaryk University 625 00 Brno Czech Republic

National Centre for Biomolecular Research Faculty of Science Masaryk University 625 00 Brno Czech Republic

Zobrazit více v PubMed

Bayona-Bafaluy MP, Acin-Perez R, Mullikin JC, Park JS, Moreno-Loshuertos R, Hu P, Perez-Martos A, Fernandez-Silva P, Bai Y, Enriquez JA. 2003. Revisiting the mouse mitochondrial DNA sequence. Nucleic Acids Res 31: 5349–5355. 10.1093/nar/gkg739 PubMed DOI PMC

Bibb MJ, Van Etten RA, Wright CT, Walberg MW, Clayton DA. 1981. Sequence and gene organization of mouse mitochondrial DNA. Cell 26: 167–180. 10.1016/0092-8674(81)90300-7 PubMed DOI

Bonin M, Oberstrass J, Lukacs N, Ewert K, Oesterschulze E, Kassing R, Nellen W. 2000. Determination of preferential binding sites for anti-dsRNA antibodies on double-stranded RNA by scanning force microscopy. RNA 6: 563–570. 10.1017/S1355838200992318 PubMed DOI PMC

Borowski LS, Dziembowski A, Hejnowicz MS, Stepien PP, Szczesny RJ. 2013. Human mitochondrial RNA decay mediated by PNPase-hSuv3 complex takes place in distinct foci. Nucleic Acids Res 41: 1223–1240. 10.1093/nar/gks1130 PubMed DOI PMC

Chauhan R, Handa R, Das TP, Pati U. 2004. Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes. Clin Exp Immunol 136: 574–584. 10.1111/j.1365-2249.2004.02463.x PubMed DOI PMC

Chen LL, Decerbo JN, Carmichael GG. 2008. Alu element-mediated gene silencing. EMBO J 27: 1694–1705. 10.1038/emboj.2008.94 PubMed DOI PMC

Dhir A, Dhir S, Borowski LS, Jimenez L, Teitell M, Rötig A, Crow YJ, Rice GI, Duffy D, Tamby C, et al. 2018. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560: 238–242. 10.1038/s41586-018-0363-0 PubMed DOI PMC

Domingo-Gil E, Esteban M. 2006. Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved. Apoptosis 11: 725–738. 10.1007/s10495-006-5541-0 PubMed DOI

Green DR, Kroemer G. 2009. Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127–1130. 10.1038/nature07986 PubMed DOI PMC

Gudkov AV, Gurova KV, Komarova EA. 2011. Inflammation and p53: a tale of two stresses. Genes Cancer 2: 503–516. 10.1177/1947601911409747 PubMed DOI PMC

Hartner JC, Schmittwolf C, Kispert A, Müller AM, Higuchi M, Seeburg PH. 2004. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279: 4894–4902. 10.1074/jbc.M311347200 PubMed DOI

Hartner JC, Walkley CR, Lu J, Orkin SH. 2009. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol 10: 109–115. 10.1038/ni.1680 PubMed DOI PMC

Hayakawa T, Noda M, Yasuda K, Yorifuji H, Taniguchi S, Miwa I, Sakura H, Terauchi Y, Hayashi J, Sharp GW, et al. 1998. Ethidium bromide-induced inhibition of mitochondrial gene transcription suppresses glucose-stimulated insulin release in the mouse pancreatic β-cell line βHC9. J Biol Chem 273: 20300–20307. 10.1074/jbc.273.32.20300 PubMed DOI

Hecht I, Toporik A, Podojil JR, Vaknin I, Cojocaru G, Oren A, Aizman E, Liang SC, Leung L, Dicken Y, et al. 2018. ILDR2 is a novel B7-like protein that negatively regulates T cell responses. J Immunol 200: 2025–2037. 10.4049/jimmunol.1700325 PubMed DOI PMC

Holden P, Horton WA. 2009. Crude subcellular fractionation of cultured mammalian cell lines. BMC Res Notes 2: 243 10.1186/1756-0500-2-243 PubMed DOI PMC

Hovanessian AG, Justesen J. 2007. The human 2′–5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′–5′ instead of 3′–5′ phosphodiester bond formation. Biochimie 89: 779–788. 10.1016/j.biochi.2007.02.003 PubMed DOI

Ibsen MS, Gad HH, Thavachelvam K, Boesen T, Desprès P, Hartmann R. 2014. The 2′–5′ oligoadenylate synthetase 3 (OAS3) enzyme potently synthesizes the 2′–5′ oligoadenylates required for RNase L activation. J Virol 88: 14222–14231. 10.1128/JVI.01763-14 PubMed DOI PMC

Kakuta S, Shibata S, Iwakura Y. 2002. Genomic structure of the mouse 2′,5′-oligoadenylate synthetase gene family. J Interferon Cytokine Res 22: 981–993. 10.1089/10799900260286696 PubMed DOI

Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, Fisher PB. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci 99: 637–642. 10.1073/pnas.022637199 PubMed DOI PMC

Kang JS, Hwang YS, Kim LK, Lee S, Lee WB, Kim-Ha J, Kim YJ. 2018. OASL1 traps viral RNAs in stress granules to promote antiviral responses. Mol Cells 41: 214–223. PubMed PMC

Kim Y, Park J, Kim S, Kim M, Kang MG, Kwak C, Kang M, Kim B, Rhee HW, Kim VN. 2018. PKR senses nuclear and mitochondrial signals by interacting with endogenous double-stranded RNAs. Mol Cell 71: 1051–1063 e1056. 10.1016/j.molcel.2018.07.029 PubMed DOI

Kjær KH, Pahus J, Hansen MF, Poulsen JB, Christensen EI, Justesen J, Martensen PM. 2014. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism. BMC Cell Biol 15: 33 10.1186/1471-2121-15-33 PubMed DOI PMC

Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin OW, Kuprash DV, et al. 2005. p53 is a suppressor of inflammatory response in mice. FASEB J 19: 1030–1032. 10.1096/fj.04-3213fje PubMed DOI

Kovacs B, Patel A, Hershey JN, Dennis GJ, Kirschfink M, Tsokos GC. 1997. Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 40: 980–982. 10.1002/art.1780400531 PubMed DOI

Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R. 2011. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res 31: 41–47. 10.1089/jir.2010.0107 PubMed DOI

Le Roy F, Silhol M, Salehzada T, Bisbal C. 2007. Regulation of mitochondrial mRNA stability by RNase L is translation-dependent and controls IFNα-induced apoptosis. Cell Death Differ 14: 1406–1413. 10.1038/sj.cdd.4402130 PubMed DOI

Lee MS, Kim B, Oh GT, Kim YJ. 2013a. OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nat Immunol 14: 346–355. 10.1038/ni.2535 PubMed DOI

Lee MS, Park CH, Jeong YH, Kim Y-J, Ha S-J. 2013b. Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8+ T-cell exhaustion. PLoS Pathog 9: e1003478 10.1371/journal.ppat.1003478 PubMed DOI PMC

Leonova KI, Brodsky L, Lipchick B, Pal M, Novototskaya L, Chenchik AA, Sen GC, Komarova EA, Gudkov AV. 2013. p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc Natl Acad Sci 110: E89–98. 10.1073/pnas.1216922110 PubMed DOI PMC

Li Y, Banerjee S, Wang Y, Goldstein SA, Dong B, Gaughan C, Silverman RH, Weiss SR. 2016. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses. Proc Natl Acad Sci 113: 2241–2246. 10.1073/pnas.1519657113 PubMed DOI PMC

Li Y, Banerjee S, Goldstein SA, Dong B, Gaughan C, Rath S, Donovan J, Korennykh A, Silverman RH, Weiss SR. 2017. Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line. eLife 6: e25687 10.7554/eLife.25687 PubMed DOI PMC

Lin RJ, Yu HP, Chang BL, Tang WC, Liao CL, Lin YL. 2009. Distinct antiviral roles for human 2′,5′-oligoadenylate synthetase family members against dengue virus infection. J Immunol 183: 8035–8043. 10.4049/jimmunol.0902728 PubMed DOI

Liu X, Fagotto F. 2011. A method to separate nuclear, cytosolic, and membrane-associated signaling molecules in cultured cells. Sci Signal 4: pl2 10.1126/scisignal.2002165 PubMed DOI

Lowman HB, Draper DE. 1986. On the recognition of helical RNA by cobra venom V1 nuclease. J Biol Chem 261: 5396–5403. PubMed

Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellåker C, Vesely C, Ponting CP, McLaughlin PJ, et al. 2014. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 9: 1482–1494. 10.1016/j.celrep.2014.10.041 PubMed DOI PMC

Mimura Y, Yazawa N, Tamaki Z, Ashida R, Jinnin M, Asano Y, Tada Y, Kubo M, Ihn H, Tamaki K. 2007. Anti-p53 antibodies in patients with dermatomyositis/polymyositis. Clin Rheumatol 26: 1328–1331. 10.1007/s10067-006-0473-1 PubMed DOI

Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H. 2002. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 21: 2914–2918. 10.1038/sj.onc.1205459 PubMed DOI

Muñoz-Fontela C, Mandinova A, Aaronson SA, Lee SW. 2016. Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat Rev Immunol 16: 741–750. 10.1038/nri.2016.99 PubMed DOI PMC

Nilsen TW. 2013. RNA structure determination using nuclease digestion. Cold Spring Harb Protoc 2013: 379–382. 10.1101/pdb.prot072330 PubMed DOI

Oh JE, Lee MS, Kim YJ, Lee HK. 2016. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production. Sci Rep 6: 19089 10.1038/srep19089 PubMed DOI PMC

Peralta S, Wang X, Moraes CT. 2012. Mitochondrial transcription: lessons from mouse models. Biochim Biophys Acta 1819: 961–969. 10.1016/j.bbagrm.2011.11.001 PubMed DOI PMC

Runge S, Sparrer KM, Lässig C, Hembach K, Baum A, Garcia-Sastre A, Söding J, Conzelmann KK, Hopfner KP. 2014. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog 10: e1004081 10.1371/journal.ppat.1004081 PubMed DOI PMC

Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13: 539–548. 10.1016/S1074-7613(00)00053-4 PubMed DOI

Silverman RH, Weiss SR. 2014. Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A. J Interferon Cytokine Res 34: 455–463. 10.1089/jir.2014.0007 PubMed DOI PMC

Sugimoto Y, Vigilante A, Darbo E, Zirra A, Militti C, D'Ambrogio A, Luscombe NM, Ule J. 2015. hiCLIP reveals the in vivo atlas of mRNA secondary structures recognized by Staufen 1. Nature 519: 491–494. 10.1038/nature14280 PubMed DOI PMC

Surovtseva YV, Shutt TE, Cotney J, Cimen H, Chen SY, Koc EC, Shadel GS. 2011. Mitochondrial ribosomal protein L12 selectively associates with human mitochondrial RNA polymerase to activate transcription. Proc Natl Acad Sci 108: 17921–17926. 10.1073/pnas.1108852108 PubMed DOI PMC

Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, et al. 2003. Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424: 516–523. 10.1038/nature01850 PubMed DOI

Takatori H, Kawashima H, Suzuki K, Nakajima H. 2014. Role of p53 in systemic autoimmune diseases. Crit Rev Immunol 34: 509–516. 10.1615/CritRevImmunol.2014012193 PubMed DOI

Taura M, Eguma A, Suico MA, Shuto T, Koga T, Komatsu K, Komune T, Sato T, Saya H, Li JD, et al. 2008. p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. Mol Cell Biol 28: 6557–6567. 10.1128/MCB.01202-08 PubMed DOI PMC

Turpin E, Luke K, Jones J, Tumpey T, Konan K, Schultz-Cherry S. 2005. Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol 79: 8802–8811. 10.1128/JVI.79.14.8802-8811.2005 PubMed DOI PMC

Vitali P, Scadden AD. 2010. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat Struct Mol Biol 17: 1043–1050. 10.1038/nsmb.1864 PubMed DOI PMC

Wang Q, Carmichael GG. 2004. Effects of length and location on the cellular response to double-stranded RNA. Microbiol Mol Biol Rev 68: 432–452. 10.1128/MMBR.68.3.432-452.2004 PubMed DOI PMC

Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K. 2004. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 279: 4952–4961. 10.1074/jbc.M310162200 PubMed DOI

Ward SV, George CX, Welch MJ, Liou LY, Hahm B, Lewicki H, de la Torre JC, Samuel CE, Oldstone MB. 2011. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci 108: 331–336. 10.1073/pnas.1017241108 PubMed DOI PMC

Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80: 5059–5064. 10.1128/JVI.80.10.5059-5064.2006 PubMed DOI PMC

Wreschner DH, McCauley JW, Skehel JJ, Kerr IM. 1981. Interferon action–sequence specificity of the ppp(A2′p)nA-dependent ribonuclease. Nature 289: 414–417. 10.1038/289414a0 PubMed DOI

Yan W, Wei J, Deng X, Shi Z, Zhu Z, Shao D, Li B, Wang S, Tong G, Ma Z. 2015. Transcriptional analysis of immune-related gene expression in p53-deficient mice with increased susceptibility to influenza A virus infection. BMC Med Genomics 8: 52 10.1186/s12920-015-0127-8 PubMed DOI PMC

Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730–737. 10.1038/ni1087 PubMed DOI

Youlyouz-Marfak I, Gachard N, Le Clorennec C, Najjar I, Baran-Marszak F, Reminieras L, May E, Bornkamm GW, Fagard R, Feuillard J. 2008. Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. Cell Death Differ 15: 376–385. 10.1038/sj.cdd.4402270 PubMed DOI

Zhu J, Zhang Y, Ghosh A, Cuevas RA, Forero A, Dhar J, Ibsen MS, Schmid-Burgk JL, Schmidt T, Ganapathiraju MK, et al. 2014. Antiviral activity of human oligoadenylate synthetases-like (OASL) is mediated by enhancing retinoic acid-inducible gene I (RIG-I) signaling. Immunity 40: 936–948. 10.1016/j.immuni.2014.05.007 PubMed DOI PMC